Results 101 to 110 of about 18,771 (177)

Takayasu arteritis and stroke

open access: yesСовременная ревматология
Takayasu arteritis (TA) is a rare inflammatory disease that primarily affects large and medium-sized arteries. The clinical picture is characterized by a wide spectrum of manifestations; in the early stages the disease is usually asymptomatic, and later ...
N. V. Pizova, A. V. Pizov
doaj   +1 more source

Pulseless electrical activity cardiac arrest: time to amend the mnemonic “4H&4T”?

open access: yesSwiss Medical Weekly, 2015
BACKGROUND:Pulseless electrical activity (PEA) cardiac arrest is characterised by a residual organised electrical activity. PEA is frequently induced by reversible conditions.
Ludovic Beun   +3 more
doaj   +1 more source

Intracranial dural arteriovenous shunts: transarterial glue embolization--experience in 115 consecutive patients

open access: yes, 2011
PURPOSE: To evaluate the effectiveness and safety of transarterial glue embolization of intracranial dural arteriovenous shunts (DAVS). MATERIALS AND METHODS: Institutional review board approval was obtained, with waiver of informed consent, for this ...
김동준
core   +1 more source

microRNAs and Markers of Neutrophil Activation as Predictors of Early Incidental Post-Surgical Pulmonary Embolism in Patients with Intracranial Tumors

open access: yes, 2020
Venous thromboembolism (VTE) is a common complication of cancer that severely increases morbidity and mortality. Patients with intracranial tumors are more likely to develop VTE than patients with cancers at other sites.
Álvaro Fernández-Pardo   +12 more
core   +1 more source

Safety and Efficacy of Bridging with Low-Molecular-Weight Heparin during Temporary Interruptions of Warfarin : A Register-Based Cohort Study

open access: yes, 2017
Low-molecular-weight heparin (LMWH) is often recommended as a bridging therapy during temporary interruptions in warfarin treatment, despite lack of evidence. The aim of this study was to see whether we could find benefit from LMWH bridging.
Renlund, Henrik   +16 more
core   +1 more source

Markov model.

open access: yes, 2016
VTE, venous thromboembolism; DVT, deep vein thrombosis; PE, pulmonary embolism; r, recurrent; LMWH, low molecular weight heparin; CRNMB = clinically relevant non-major bleed event; ICH = intracranial haemorrhage; MB = major bleed; MI = myocardial ...
J. Stevanović (3238986)   +5 more
core   +1 more source

Recurrent VTE, bleeding complications and other adverse events and related costs within a hypothetical patient population of 10,000 subjects receiving dabigatran and VKA over a lifetime horizon.

open access: yes, 2016
VKA, vitamin K antagonists; VTE, venous thromboembolism; DVT, deep vein thrombosis; PE, pulmonary embolism; r, recurrent; LMWH, low molecular weight heparin; CRNMB = clinically relevant non-major bleed event; ICH = intracranial haemorrhage; MB = major ...
J. Stevanović (3238986)   +5 more
core   +1 more source

Urokinase prophylactic anticoagulation in children with nephrotic syndrome: a multicenter retrospective cohort study

open access: yesBMC Nephrology
Objective To analyze the clinical effect of urokinase on the prevention of thrombosis in children with primary nephrotic syndrome. Methods A total of 370 children diagnosed with primary nephrotic syndrome (PNS) in the Children’s Hospital of Soochow ...
Zhen Wang   +5 more
doaj   +1 more source

Cost parameters applied in the model.

open access: yes, 2016
VKA, vitamin K antagonists; LMWH, low molecular weight heparins; INR, international normalised ratio; MCRB, major or clinically relevant bleeding; DVT, deep vein thrombosis; PE, pulmonary embolism; CRNMB = clinically relevant non-major bleed event; ICH =
J. Stevanović (3238986)   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy